PAR 2.38% 21.5¢ paradigm biopharmaceuticals limited..

The best part of the 2019 activities forecast imo is the...

  1. 61 Posts.
    lightbulb Created with Sketch. 4
    The best part of the 2019 activities forecast imo is the potential for FDA fast tracking. The fact that they are not just treating the symptoms, but solving the underlying problem (opioid abuse), will really foster attention in the US. Exiting times ahead. 
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.